techMARK (TASX)

5,711.16
   
  • Change Today:
    -8.86
  • 52 Week High: 6,043.41
  • 52 Week Low: 4,135.10

Latest ShareCast News

GSK's cholestatic pruritus treatment Lynavoy gets US FDA approval

By Josh White

Date: Thursday 19 Mar 2026

(Sharecast News) - GSK said on Thursday that the US Food and Drug Administration has approved its drug 'Lynavoy', or linerixibat, for the treatment of cholestatic pruritus in adults with primary biliary cholangitis, marking the first approved therapy in the US for the condition.

techMARK Regulatory News

Transaction in Own Shares 20-Mar-2026 13:52 RNS
Dealing Disclosure under Rule 8 Takeover Code 20-Mar-2026 13:50 RNS
Dealing Disclosure under Rule 8 Takeover Code 20-Mar-2026 13:49 RNS
Form 8.3 NCC GROUP PLC 20-Mar-2026 13:43 RNS
Director/PDMR Shareholding 20-Mar-2026 13:42 RNS

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

 

Price Data

Price 5,711.16
Change Today -8.86
% Change -0.15 %
19-Mar-26 Close 5,720.02

Top Risers

Price Change
RSW 3,855.00p +2.5%
VOD 109.90p +2.1%
NCC 120.20p +1.5%
OXIG 2,440.00p +1.5%
BVC 14.00p +1.4%
FLTR 7,950.00p +0.6%
SN. 1,210.00p +0.4%
GNS 2,580.00p +0.2%
SGE 841.00p +0.2%
GSK 1,957.50p +0.1%

Top Fallers

Price Change
CCC 2,840.00p -3.3%
XPP 1,318.00p -2.4%
QQ. 485.40p -1.9%
OXB 612.00p -1.0%
BA. 2,297.00p -0.5%
BT.A 217.00p -0.3%
XAR 106.50p -0.0%
DIA 288.00p -0.0%
RM. 93.00p -0.0%

Top of Page